Anadolu Agency's Morning Briefing - Nov. 16, 2021
Daily briefing on novel coronavirus pandemic worldwide, Turkey, other developments
Anadolu Agency is here with a rundown of the latest developments in Turkey, around the world, and the coronavirus pandemic.
Developments in Turkey, coronavirus pandemic and other news
Turkey has administered over 118.5 million doses of COVID-19 vaccines since it launched an immunization drive in January, according to official figures released Monday.
More than 56.86 million people have been given a first vaccine dose and over 49.7 million have been fully vaccinated, the Health Ministry said.
Turkey has also given third booster shots to over 11.68 million people.
The ministry recorded 23,852 new coronavirus cases, 215 deaths and 25,258 recoveries over the past day.
Turkey has started a new anti-terror operation in the country's eastern and southeastern provinces against the PKK terror group, the Interior Ministry announced Monday.
The operation in Bingol and Diyarbakir provinces, dubbed Eren Winter-3 Martyr Gendarmerie Major Ercan Kurt Lice-Saggozu, aims to completely eliminate separatist terror groups and neutralize terrorist hideouts in the region, the ministry said in a statement.
Other global developments
EU foreign ministers decided Monday to broaden the sanctions criteria in response to the Belarus migrant crisis, providing a legal basis for restrictive measures against airlines and travel agencies involved in transporting migrants to the bloc’s borders.
NATO Secretary General Jens Stoltenberg urged Russia on Monday to reduce tensions after an “unusual concentration of forces” in and around Ukraine.
An explosion in Liverpool on Sunday that left one person dead and another wounded has been declared a “terrorist incident,” British police said Monday.
The terror threat level in the UK on Monday was raised from “substantial” to “severe.”
Russia could step in as a mediator to help resolve the border migrant crisis between Belarus and the EU, Kremlin spokesman Dmitry Peskov said Monday.
The US has not made any decision yet on a potential waiver for India after it began receiving deliveries of an advanced surface-to-air missile system from Russia, the State Department said Monday.
Spanish regulators gave local pharmaceutical company HIPRA the green light Monday to begin a Phase 2 clinical trial of its COVID-19 vaccine.
Anadolu Agency website contains only a portion of the news stories offered to subscribers in the AA News Broadcasting System (HAS), and in summarized form. Please contact us for subscription options.